Ureido-thiazole glucokinase activators
US7884210B2 · kind B2 · utility
4Cited by
53References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2006 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Jul 14, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of general formula (I)wherein the compounds are of the class ureido-thiazole glucokinase activators, useful for the treatment of various diseases, for example, type 2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.